Illumina Appoints Dr. Frances Arnold to Its Board of Directors
January 28 2016 - 6:30AM
Business Wire
Illumina, Inc. (NASDAQ: ILMN) today announced that Dr.
Frances Arnold has joined the company’s Board of Directors. Dr.
Arnold manages a research group at the California Institute of
Technology and is the Director of the Donna and Benjamin M. Rosen
Bioengineering Center.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20160128005205/en/
Dr. Frances Arnold (Photo: Business
Wire)
Dr. Arnold joined the California Institute of Technology in 1986
and has served as a Visiting Associate, Assistant Professor,
Professor and Director. Her laboratory focuses on protein
engineering by directed evolution, with applications in alternative
energy, chemicals and medicine.
“We are very pleased to welcome Dr. Arnold to our board and look
forward to leveraging her experience and expertise in life sciences
and medicine,” said Jay Flatley, Illumina Chief Executive Officer.
“We value the perspective and passion that she will bring to the
role as we plan for growth in our clinical and research
markets.”
Dr. Arnold is the recipient of numerous honors, including
induction into the National Inventors Hall of Fame (2014), Fellow
of the National Academy of Inventors (2014), the ENI Prize in
Renewable and Nonconventional Energy (2013), the US National Medal
of Technology and Innovation (2011), and the Charles Stark Draper
Prize of the US National Academy of Engineering (2011). She has
been elected to membership in all three US National Academies, of
Science, Medicine, and Engineering and the American Academy of Arts
and Sciences.
About Illumina
Illumina is improving human health by unlocking the power
of the genome. Our focus on innovation has established us as the
global leader in DNA sequencing and array-based technologies,
serving customers in the research, clinical and applied markets.
Our products are used for applications in the life sciences,
oncology, reproductive health, agriculture and other emerging
segments. To learn more, visit www.illumina.com and
follow @illumina.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160128005205/en/
Illumina, Inc.Investors:Rebecca Chambers,
858-255-5243rchambers@illumina.comorMedia:Eric Endicott,
858-882-6822pr@illumina.com
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Apr 2023 to Apr 2024